Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection
Clinical trial NCT05713279 · TERMINATED
Trial details
- NCT number
- NCT05713279
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2023-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.